Vancomycin-resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection

Pediatric Blood and Cancer

Volumn 52, Issue 2, 2009, Pages 300-302

  Kosack, Amanda ^a   Riedel, Elyn ^a   Kiehn, Timothy E ^a   Small, Trudy N ^a   Wexler, Leonard H ^a   Dunkel, Ira J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colonization; Infection; Mucositis; Neutropenia; Vancomycin resistant enterococcus

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; EYE INFECTION; FEMALE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION; ANTIBIOTIC RESISTANCE; ENTEROCOCCUS; INCIDENCE; NEOPLASM; RETROSPECTIVE STUDY; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENTEROCOCCUS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 59449101335     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21793     Document Type: Article

References (13)

1. Chavers LS, Mosert SA, Benjamin WH, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 2003;53:159-171.
2. Patel R. Clinical Impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003;51:S13-S21.
3. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: Colonization, infection, detection and treatment. Mayo Clin Proc 2006;81:529-536.
4. Kuehnert MJ, Jerniga JA, Pullen AJ, et al. Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 1999;20:660-663.
5. Nourse C, Murphy H, Byrne C, et al. Control of a nosocomial outbreak of vancomycin-resistant enterococcus faecium in a paediatric oncology unit: Risk factors for colonisation. Eur J Pediatr 1998;157:20-27.
6. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1998;16:1141-1154.
7. Naz SN, Sleemi A, Pikis A, et al. Vancomycin-resistant enterococcus faecium colonization in children. J Clin Microbiol 1999;37:413-416.
8. Henning KJ, Delencaste H, Eagan J, et al. Vancomycin-resistant enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996;15:848-854.
9. Rubin LG, Tucci V, Cercenado E, et al. Vancomycin-resistant enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-705.
10. Tsiatis AC, Manes B, Billheimer D, et al. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Bone Marrow Transplant 2004;33:937-941.
11. Carretto E, Barbarini D, Locatelli F, et al. Vancomycin-resistant enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: Clinical and microbiological features. Haematologica 2000;85:1158-1164.
12. Baran J, Riederer K, Ramanathan J, et al. Recurrent vancomycin-resistant enterococcus bacteremia: Prevalence, predisposing factors, and strain relatedness. Clin Infect Dis 2000;32:1381-1383.
13. Zaas AK, Song X, Tucker P, et al. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002;35:1139-1146.